Canaccord Genuity ( (CCORF)) has released its Q2 earnings. Here is a breakdown of the information Canaccord Genuity presented to its investors. Canaccord Genuity Group Inc. is a prominent ...

Canaccord raised the firm’s price target on Coeur Mining (CDE) to $9.50 from $9 and keeps a Buy rating on the shares. The firm said they delivered a very strong quarter, exceeding consensus ...

Canaccord Genuity Group Inc. reported net income of $16.9 million for its most recent quarter as its wealth management and capital markets divisions continued to exhibit better performance. The ...

Canaccord Genuity analyst Elyse Shapiro maintained a Buy rating on Neuren Pharmaceuticals Limited (NURPF – Research Report) on November 7 and set a price target of A$29.00. The company’s ...

Good morning, ladies and gentlemen. Thank you for standing by. I'd like to welcome everyone to the Canaccord Genuity Group Inc. Fiscal 2025 Second Quarter Results Conference Call. All lines have ...

the Maglan unit, fighters from the 636 Battalion, and additional forces operated, the IDF reported Saturday evening. Troops also arrested a wanted suspect and interrogated other suspects.

Canaccord lowered the firm’s price target on SolarEdge (SEDG) to $14.50 from $27 and keeps a Hold rating on the shares. The firm noted they completed a strategic review and will take a $1B ...

Canaccord lowered the firm’s price target on Vivid Seats (SEAT) to $6 from $7 and keeps a Buy rating on the shares. The firm said they reported mixed Q3 results, with marketplace GOV coming in ...

Canaccord Genuity Group Inc. recorded strong growth in wealth-management and capital-markets divisions for its fiscal second quarter, as reported by BNN Bloomberg. Revenue for the Canadian firm surged ...